shows the kinetic of expanded T-cell subpopulations in MDS patients during Azacitidine treatment at different time points (every 3 months). Expansions already present at baseline or emerged during therapy are represented as continuous or dashed lines respectively. By convention values below the mean + 3 standard deviations are represented with a value of 0. 0 %.